Session 3
Clinical applications & Trial

Programm

• 14:00 – 14:12 10 Min. 2 Min.

  Interim report on the NOC/SNMT clinical study: Promising early signs of pain alleviation related to magnetic hyperthermia treatment in locally advanced pancreatic cancer

  • Prof. Quentin Andrew Pankhurst (London, GB)

   Clinical Applications & Trials
• 14:12 – 14:24 10 Min. 2 Min.

  Progress report on the H2020 HYPERBOOST consortium: Hyperthermia boosting the effect of radiotherapy

  • Dr. Johannes Crezee (Amsterdam, NL)

   Clinical Applications & Trials
• 14:24 – 14:36 10 Min. 2 Min.

  Long-term results in children and adolescents with refractory and recurrent non-testicular germ cell tumors: A success story for regional deep hyperthermia combined with platinum-based chemotherapy

  • PD Dr. Ruediger Wessalowski (Düsseldorf, DE)

   Clinical Applications & Trials
• 14:36 – 14:48 10 Min. 2 Min.

  Does CRS + HIPEC improves survival compared to crs alone in advanced epithelial ovarian cancer? 7 year experience from tertiary cancer centre in India

  • Prof M D Ray (New Delhi, IN)

   Clinical Applications & Trials
• 14:48 – 15:00 10 Min. 2 Min.

  The continuous thermal dose-effect relationship in locoregional recurrent breast cancer patients treated with postoperative re-irradiation combined with hyperthermia

  • Drs. C. Paola Tello Valverde (Amsterdam, NL)

   Clinical Applications & Trials
• 15:00 – 15:12 10 Min. 2 Min.

  Trial in progress: First-in-human phase I study of THE001 combined with regional hyperthermia in patients with locally advanced or metastatic soft tissue sarcoma

  • Prof. Dr. Lars H. Lindner (Munich, DE)

   Clinical Applications & Trials
• 15:12 – 15:24 10 Min. 2 Min.

  Hyperthermia and radiotherapy in management of recurrent head and neck cancers: A systematic review and meta-analysis

  • Niloy Ranjan Datta Niloy Datta (Wardha, IN)

   Clinical Applications & Trials